|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 1765292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05759527.4 |
| Date of filing the European patent application | 2005-06-10 | |
| (97) | Date of publication of the European application | 2007-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-04 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (86) | Number | PCT/US2005/020588 |
| Date | 2005-06-10 |
| (87) | Number | WO 2005/123039 |
| Date | 2005-12-29 |
| (30) | Number | Date | Country code |
| 579191 P | 2004-06-12 | US |
| (72) |
HIRSH, Jane, US
FLEMING, Alison, B., US
RARIY, Roman, V., US
KLIBANOV, Alexander, M., US
|
| (73) |
Collegium Pharmaceutical, Inc.,
400 Highland Corporate Drive, Cumberland, RI 02864,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Nuo piktnaudžiavimo apsaugotos vaistų formos |
| ABUSE-DETERRENT DRUG FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2018-05-22 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-06-10 |